Cargando…

SARS‐CoV‐2 and the Liver: Considerations in Hepatitis B and Hepatitis C Infections

Detalles Bibliográficos
Autor principal:	Reddy, K. Rajender
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242007/ https://www.ncbi.nlm.nih.gov/pubmed/32489654 http://dx.doi.org/10.1002/cld.970

Ejemplares similares

Hepatitis B and C screening in hospitalized patients with SARS-CoV-2 infection()
por: Gómez Camarero, Judith, et al.
Publicado: (2022)

Interaction between hepatitis B virus and SARS-CoV-2 infections
por: Xiang, Tian-Dan, et al.
Publicado: (2021)

SARS-CoV-2 induced hepatic injuries and liver complications
por: Saeed, Umar, et al.
Publicado: (2022)

SARS-CoV-2 infection in patients with autoimmune hepatitis
por: Marjot, Thomas, et al.
Publicado: (2021)

Severe acute hepatitis in a person with HIV and simultaneous infection with hepatitis C virus and SARS-CoV-2
por: Santos, Marta, et al.
Publicado: (2023)

Severe acute hepatitis in a person with HIV and simultaneous infection with hepatitis C virus and SARS-CoV-2
por: Santos, Marta, et al.
Publicado: (2023)

Clinical Characteristics of Hospitalized Patients with SARS-CoV-2 and Hepatitis B Virus Co-infection
por: Chen, Xiaoping, et al.
Publicado: (2020)

Effect of SARS-CoV-2 coinfection was not apparent on the dynamics of chronic hepatitis B infection
por: Yu, Rentao, et al.
Publicado: (2021)

SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19
por: Wang, Yijin, et al.
Publicado: (2020)

SARS-CoV-2-Induced Autoimmune Hepatitis
por: Martini, Nora, et al.
Publicado: (2023)

Management of Hepatitis C Before and After Liver Transplantation in the Era of Rapidly Evolving Therapeutic Advances
por: Bunchorntavakul, Chalermrat, et al.
Publicado: (2014)

Severe Cholestatic Hepatitis Secondary to SARS-CoV-2
por: Lindholm, Christopher R., et al.
Publicado: (2022)

Autoimmune hepatitis triggered by SARS-CoV-2 vaccination
por: Vuille-Lessard, Élise, et al.
Publicado: (2021)

Mechanism of SARS-CoV-2 Invasion into the Liver and Hepatic Injury in Patients with COVID-19
por: Zhang, XiaoTian, et al.
Publicado: (2022)

Schistosomiasis, hepatitis B and hepatitis C co-infection
por: Gasim, Gasim I, et al.
Publicado: (2015)

SARS-CoV-2 Infection and the Liver
por: Morgan, Katie, et al.
Publicado: (2020)

SARS-CoV-2 infection: a hurricane that does not ignore chronic hepatitis
por: Sagnelli, Caterina, et al.
Publicado: (2022)

SARS‐CoV‐2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease
por: Duengelhoef, Paul, et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Response in Patients With Autoimmune Hepatitis
por: Schneider, Lisa, et al.
Publicado: (2022)

Drug induced hepatitis and SARS-CoV-2 vaccination: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Hepatitis C Virus and Hepatitis B Virus Co-Infection
por: Shih, Yi-Fen, et al.
Publicado: (2020)

Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection
por: Xiang, Tiandan, et al.
Publicado: (2021)

Kidney Disease and Sars-coV-2 Infection: Challenges and Considerations for Nursing
por: Rivera, Sherry, et al.
Publicado: (2022)

Reply to: Correspondence relating to “SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19”
por: Wang, Yijin, et al.
Publicado: (2020)

Human liver organoid derived intra-hepatic bile duct cells support SARS-CoV-2 infection and replication
por: Lui, Vincent Chi-Hang, et al.
Publicado: (2022)

Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2
por: Zhang, Jianguo, et al.
Publicado: (2022)

Liver dysfunction and SARS-CoV-2 infection
por: Gracia-Ramos, Abraham Edgar, et al.
Publicado: (2021)

SARS-CoV-2 infection and liver involvement
por: Luo, Mingjia, et al.
Publicado: (2022)

Effect of SARS-CoV-2 infection on the liver
por: Sanyaolu, Adekunle, et al.
Publicado: (2023)

Development of Mouse Hepatitis Virus and SARS-CoV Infectious cDNA Constructs
por: Baric, R. S., et al.
Publicado: (2005)

SARS-CoV-2 infection associated with hepatitis in an infant with X-linked severe combined immunodeficiency
por: van Oers, Nicolai S.C., et al.
Publicado: (2021)

SARS‐CoV‐2 infection and paediatric endocrine disorders: Risks and management considerations
por: Miller, Ryan, et al.
Publicado: (2021)

Considerations for Pooled Testing of Employees for SARS-CoV-2
por: Schulte, Paul A., et al.
Publicado: (2021)

Severe acute hepatitis in children: investigate SARS-CoV-2 superantigens
por: Brodin, Petter, et al.
Publicado: (2022)

Drug-induced hepatitis (DIH) after SARS-CoV-2 vaccination
por: Asgarzdeh, Ali, et al.
Publicado: (2023)

Analysis of Gastrointestinal and Hepatic Manifestations of SARS-CoV-2 Infection in 892 Patients in Queens, NY
por: Ferm, Samson, et al.
Publicado: (2020)

Maternal and Neonatal Outcomes in Pregnant Women With SARS-CoV-2 Infection Complicated by Hepatic Dysfunction
por: Choudhary, Anisha, et al.
Publicado: (2022)

Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists
por: Bouadma, Lila, et al.
Publicado: (2020)

Pediatric Acute Liver Failure Due to Type 2 Autoimmune Hepatitis Associated With SARS-CoV-2 Infection: A Case Report
por: Osborn, Julie, et al.
Publicado: (2022)

Anakinra/convalescent-anti-SARS-CoV-2-plasma/prednisolone: Aggravation of SARS-CoV-2 hepatitis, SARS-CoV-2 viraemia and off-label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u0ul1juvu1umdrinovooc5in65